High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH).
Affiliation
The Christie Hospital NHS Foundation Trust, ManchesterIssue Date
2011-12
Metadata
Show full item recordCitation
High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH). 2011, 22 (12):2696 Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdr431PubMed ID
22021821Type
ArticleLanguage
enISSN
1569-8041ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdr431
Scopus Count
Related articles
- [Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan].
- Authors: Schnaiter A, Hiddemann W
- Issue date: 2014 Oct
- Case report: Secondary failure to tolvaptan in a patient with SCLC and paraneoplastic SIADH.
- Authors: Menzi S, Jaramillo SD, Pfister S, Schefer H, Jehle AW
- Issue date: 2024
- Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
- Authors: Harbeck B, Lindner U, Haas CS
- Issue date: 2016 Sep
- Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer.
- Authors: Hainsworth JD, Workman R, Greco FA
- Issue date: 1983 Jan 1
- Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
- Authors: Bordi P, Tiseo M, Buti S, Regolisti G, Ardizzoni A
- Issue date: 2015 Apr 28